Health
Emergent BioSolutions Stock Jumps 23% After FDA Approves Smallpox Vaccine for MPOx – MarketWatch
- Emergent BioSolutions Stock Jumps 23% After FDA Approves Smallpox Vaccine for MPOxMarketWatch
- Emergent Bio shares climb as smallpox vaccine gets U.S. approval vs. MPOXReuters
- Emergent BioSolutions shares surge after FDA approval of Mpox vaccineInvestors’ daily life
- Emergent BioSolutions Shares Soar After FDA Approval of Mpox VaccineBarron’s
- U.S. FDA approves Emergent’s smallpox vaccine for people at high risk of the diseaseUS and World News
